Extending survival by reducing sudden death with implantable cardioverter-defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies

Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co-morbidities

(2017) Giuseppe Boriani et al.   EUROPEAN JOURNAL OF HEART FAILURE

Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials

(2017) STAVROS STAVRAKIS et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Should Nonischemic CRT Candidates Receive CRT-P or CRT-D? ∗

(2017) Wayne C. Levy   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Declining Risk of Sudden Death in Heart Failure

(2017) Li Shen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator

(2017) Lucas N. Marzec et al.   JAMA Cardiology

Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy

(2017) Sana M. Al-Khatib et al.   JAMA Cardiology

Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy

(2016) Harsh Golwala et al.   CIRCULATION

Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis

(2016) Scott D. Solomon et al.   EUROPEAN JOURNAL OF HEART FAILURE

Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA

(2016) Milton Packer   EUROPEAN JOURNAL OF HEART FAILURE

Cardiac device therapy in patients with left ventricular dysfunction and heart failure: ‘real-world’ data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital)

(2016) Giuseppe Boriani et al.   EUROPEAN JOURNAL OF HEART FAILURE

Reframing the association and significance of co-morbidities in heart failure

(2016) Filippos Triposkiadis et al.   EUROPEAN JOURNAL OF HEART FAILURE

The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers

(2016) Anne Christine Ruwald et al.   EUROPEAN JOURNAL OF HEART FAILURE

The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database

(2016) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

(2016) Maria G. Crespo-Leiro et al.   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

(2016) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States

(2016) Daniel J. Friedman et al.   JAMA Cardiology

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

(2015) Giuseppe Boriani et al.   EUROPACE

Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials

(2015) Christopher J. Rush et al.   JACC-Heart Failure

The MOGE(S) Classification of Cardiomyopathy for Clinicians

(2014) Eloisa Arbustini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcomes of Implantable Cardioverter-Defibrillator Use in Patients With Comorbidities

(2014) Benjamin A. Steinberg et al.   JACC-Heart Failure

Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators

(2013) Pasquale Santangeli et al.   ANNALS OF INTERNAL MEDICINE

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: Does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials

(2013) Paul L. Hess et al.   HEART RHYTHM

ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy

(2013) Andrea M. Russo et al.   HEART RHYTHM

Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis

(2010) D. A. M. J. Theuns et al.   EUROPACE

Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management

(2010) F. Braunschweig et al.   EUROPACE

Role of drugs and devices in patients at risk of sudden cardiac death

(2010) Giuseppe Boriani et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Defibrillator Implantation Early after Myocardial Infarction

(2009) Gerhard Steinbeck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expenditure and value for money: the challenge of implantable cardioverter defibrillators

(2009) G. Boriani et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE